Non-viral infections and antimicrobial resistance in the time of COVID-19: what to expect?

Expert Rev Clin Pharmacol. 2022 Aug;15(8):907-909. doi: 10.1080/17512433.2022.2108403. Epub 2022 Aug 3.

Authors

Lyudmila Boyanova¹, Rumyana Markovska¹, Ivan Mitov¹, Raina Gergova¹

Affiliation

¹ Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.

PMID: 35912839
DOI: 10.1080/17512433.2022.2108403

No abstract available

Keywords: Antibiotics; COVID-19; antifungals; bacterial infections; coinfections; fungal infections; resistance.

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
COVID-19*
Drug Resistance, Bacterial
Humans
SARS-CoV-2

Substances

Anti-Bacterial Agents